[Anemia in acute kidney failure following peritonitis--its causes, development and treatment].
Twelve patients presenting postoperative acute renal failure (ARF), developing after peritonitis, are subjected to follow-up study. A comparative assessment of the renal function and anemic syndrome is done during three different periods: immediately after the operative intervention, after renal failure development, and at treatment completed. For the purpose a number of indicators are monitored, namely: hemoglobin, hematocrit, erythrocytes, blood platelets, urea, creatinine, serum calcium and iron levels, diuresis and creatinine clearance (Ccr). Two patients are given human recombinant erythropoietin (rHuEpo). As demonstrated by the results, erythropoietin (Epo) deficiency is the underlying cause of concurrent anemia occurring in postoperative ARF; the anemia syndrome develops parallel to renal failure development. In patients given rHuEpo the anemia lends itself readily to control, renal failure subsides completely within shorter periods of time, and the incidence of hemorrhagic accidents is reduced.
Bocheva
V
V
Mushekov
V
V
D058186:Acute Kidney Injury / Q000150:complications* / Q000628:therapy; D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology*; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000172:deficiency / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000150:complications* / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin
Anemiia pri ostra bŭbrechna nedostatŭchnost sled peritonit--prichini, razvitie, lechenie.